Santarus' P2P Acquisition

Santarus raised a round of funding on January 03, 2014. Investors include Salix Pharmaceuticals.

Santarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention and treatment of gastrointestinal diseases and disorders. The company's …

Articles about Santarus' P2P Acquisition: